Q-omics provides the consensus-scored LINC01715 profile across patient tissues and cancer cell-line models. LINC01715 expression is associated with patient survival in 25 of 34 cancer types, with the highest sampling consensus in BLCA. Among the 18 cancer types available for tumor–normal comparison, LINC01715 is differentially expressed in 10, with the highest sampling consensus in KICH. Additionally, LINC01715 RNA expression shows 15,563 significant gene co-expression associations, with the highest sampling consensus in ACC. Together, these results highlight BLCA, KICH, and ACC as cancer lineages where LINC01715 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01715 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01715 survival associations across molecular data types. LINC01715 RNA expression shows survival associations in the most cancer types (25). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01715 RNA expression–survival associations across cancer types. High LINC01715 expression shows unfavorable associations in BLCA and LGG, but favorable associations in PAAD, UCS, ACC and ESCA. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .008). Together, the overview and detailed table identify BLCA as the clearest survival context for LINC01715 RNA expression.
This table summarizes LINC01715 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01715. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01715 shows lower tumor expression in KICH, THCA, UCEC, BRCA and BLCA and higher tumor expression in LIHC. The KICH box plot shows higher LINC01715 RNA expression in normal versus tumor tissue (log2 FC = −1.161, t-test p < 0.001).
This table shows molecular features associated with LINC01715 in patient tissues and cancer cell lines. In patient samples, LINC01715 shows the broadest associations at the RNA and protein expression levels, with ACC recurring as the lineage with the largest associated feature set.
